My PhD project focuses on optimizing the clinical management of lung cancer using liquid biopsies.
Medicine & Life Sciences
# Biomarkers # Erbb Receptors # Immunotherapy # Non-Small Cell Lung Carcinoma # Tumor Biomarkers
# Adverse Events # Cancer # Diagnostic
van Delft, F. , Koffijberg, E. , Retel, V., Schuurbiers, M., van Rossum, H., van den Heuvel, M. , & IJzerman, M. (2020). Comparing Methods of Longitudinal SERUM Tumor Marker Analisis in Response Monitoring of Immunotherapy Treated NON-SMALL Cell LUNG Cancer Patients. Value in health, 23(Suppl. 2), S472-S472. [PCN279]. https://doi.org/10.1016/j.jval.2020.08.416
van Delft, F. , Koffijberg, H. , Retèl, V., van den Heuvel, M. , & Ijzerman, M. (2020). The validity and predictive value of blood-based biomarkers in prediction of response in the treatment of metastatic non-small cell lung cancer: A systematic review. Cancers, 12(5), . https://doi.org/10.3390/cancers12051120
Courses Academic Year 2021/2022
Courses in the current academic year are added at the moment they are finalised in the Osiris system. Therefore it is possible that the list is not yet complete for the whole academic year.